Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$376M |
| 2 |
Apple
AAPL
|
+$264M |
| 3 |
STJ
St Jude Medical
STJ
|
+$263M |
| 4 |
Microsoft
MSFT
|
+$260M |
| 5 |
Alibaba
BABA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$261M |
| 3 |
Gilead Sciences
GILD
|
+$247M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$232M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 4.73% |
| 3 | Financials | 4.3% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Energy | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
AstraZeneca
AZN
$250B
| $8.83M | 0.01% |
146,216
+139,736
| +2,156% | +$8.12M |
|
|
GAS
902
DELISTED
AGL Resources Inc
GAS
| $8.81M | 0.01% |
133,616
-107,278
| -45% | -$7.05M |
|
903
Herbalife
HLF
$1.19B
| $8.79M | 0.01% |
300,488
+55,934
| +23% | +$1.67M |
|
904
BHP
BHP
$223B
| $8.79M | 0.01% |
344,951
+212,855
| +161% | +$5.3M |
|
905
PUT
Abbott
ABT
$187B
| $8.78M | 0.01% |
223,300
+83,500
| +60% | +$3.32M |
|
906
PUT
Direxion Daily Small Cap Bear 3x ETF
TZA
$217M
| $8.75M | 0.01% |
608
+54
| +10% | +$858K |
|
|
907
PUT
BHP
BHP
$223B
| $8.75M | 0.01% |
343,474
+250,767
| +270% | +$6.25M |
|
908
CALL
Skyworks Solutions
SWKS
$10.1B
| $8.74M | 0.01% |
138,200
-75,400
| -35% | -$5.13M |
|
909
Keurig Dr Pepper
KDP
$41.3B
| $8.71M | 0.01% |
90,163
+14,063
| +18% | +$1.29M |
|
910
CALL
Neurocrine Biosciences
NBIX
$16.2B
| $8.68M | 0.01% |
191,000
+182,300
| +2,095% | +$8.39M |
|
911
CALL
Sarepta Therapeutics
SRPT
$1.77B
| $8.67M | 0.01% |
+454,800
| New | +$8.42M |
|
|
ENLK
912
DELISTED
EnLink Midstream Partners, LP
ENLK
| $8.67M | 0.01% |
521,337
+61,645
| +13% | +$900K |
|
913
Tyson Foods
TSN
$20.6B
| $8.66M | 0.01% |
129,670
-325,152
| -71% | -$21.1M |
|
914
CALL
American International
AIG
$42.4B
| $8.65M | 0.01% |
163,500
-143,100
| -47% | -$7.9M |
|
915
CALL
Berkshire Hathaway Class B
BRK.B
$1.13T
| $8.64M | 0.01% |
59,700
+26,100
| +78% | +$3.73M |
|
916
Plains GP Holdings
PAGP
$5.02B
| $8.63M | 0.01% |
310,887
+20,092
| +7% | +$518K |
|
917
AptarGroup
ATR
$8.63B
| $8.63M | 0.01% |
109,044
+40,063
| +58% | +$3.1M |
|
918
Republic Services
RSG
$64.5B
| $8.6M | 0.01% |
167,590
+23,692
| +16% | +$1.14M |
|
|
CBI
919
DELISTED
Chicago Bridge & Iron Nv
CBI
| $8.58M | 0.01% |
247,824
+3,013
| +1% | +$111K |
|
920
Vertex Pharmaceuticals
VRTX
$123B
| $8.57M | 0.01% |
99,572
+1,684
| +2% | +$146K |
|
921
PUT
MetLife
MET
$64.3B
| $8.55M | 0.01% |
240,781
+130,601
| +119% | +$5.09M |
|
|
XLNX
922
DELISTED
Xilinx Inc
XLNX
| $8.53M | 0.01% |
184,870
+25,625
| +16% | +$1.17M |
|
923
CALL
Bristol-Myers Squibb
BMY
$131B
| $8.53M | 0.01% |
115,900
-138,600
| -54% | -$9.79M |
|
|
DWA
924
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $8.52M | 0.01% |
208,370
+186,159
| +838% | +$6.72M |
|
|
TIF
925
PUT
DELISTED
Tiffany & Co.
TIF
| $8.51M | 0.01% |
140,400
+27,300
| +24% | +$1.81M |
|
Similar funds
Barclays's Q2 2016 Portfolio in Review
As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
- Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
- Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
- Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
- Barclays opened 709 new positions and closed 569 in Q2 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.